Efficacy and Safety of Cadonilimab in Combination with Pulocimab and Paclitaxel As Second-Line Therapy in Patients with Advanced Gastric or Gastroesophageal Junction (G/GEJ) Cancer Who Failed Immunochemotherapy: A Multicenter, Double-Blind, Randomized Trial.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined